David M. Fox | Washington, D.C. | Hogan Lovells

David M. Fox
Fox David
  • Overview
  • Experience
  • Credentials
  • Insights and events
quote mark

"David Fox is a go-to attorney for clients bringing new products through review, as well as advising on related IP issues."

Chambers USA

David Fox is a leading authority on the regulation of prescription and over-the-counter drugs, biological products, combination products, and controlled substances. 

He advises management teams, from start-ups to the largest global pharmaceutical and biotechnology companies, on matters before the Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA). David is closely integrated with funding sources for the industry and is frequently retained as a strategic advisor on assessing the value of life sciences assets. Known for his collaborative approach to complex regulatory issues, David has successfully resolved numerous disputes between sponsors and staff at FDA on products that raise novel regulatory issues. As a former senior lawyer for FDA and throughout his career in private practice, David has been deeply immersed in the regulatory side of the Hatch-Waxman Act, including pioneer-generic disputes and numerous cases of first impression involving exclusivity issues, Orange Book listings, and patent term extensions. 

David previously led our Pharmaceutical and Biotechnology practice group and served on the firm's global Life Sciences management team.

During his FDA tenure, David received the Secretary’s Award of Merit and an FDA Special Citation for his work on the FDA Tobacco Rule. David is a founding member of the Kitalys Institute to support interventions that delay the onset of diseases of aging, and David is on the Advisory Board of the Cancer Support Community. David also serves as pro bono counsel on a variety of programs to improve patient and care-giver welfare.

quote mark

"We love the tremendous expertise that David Fox brings to our strategic product development initiatives."

Chambers 2013

Credentials

Education
  • J.D., New York University School of Law, 1989
  • B.A., College of William & Mary, 1985
Bar admissions and qualifications
  • District of Columbia
  • New York

Recognition

Life Sciences: Regulatory/Compliance (Nationwide), Band 1

Chambers USA

2007-2023
Healthcare: Pharmaceutical/Medical Products Regulatory (District of Columbia), Band1

Chambers USA

2010-2023
Life Sciences: Regulatory/Compliance (USA)

Chambers Global

2021
Life Sciences Hall of Fame

LMG Life Sciences

2020
FDA Law

Best Lawyers in America

2018-2022
Healthcare: Life Sciences, Hall of Fame

Legal 500 US

2019-2020,2023
Healthcare: Life Sciences, Leading Lawyer

Legal 500 US

2013-2014, 2016-2018
Thought Leaders, USA, Life Sciences - Regulatory

Who's Who Legal

2023
Selected to Super Lawyers

2013-2018
Washington's Top Lawyers: Food and Drug

Washingtonian

2009, 2011, 2013, 2014
Most Highly Regarded Firms for Life Sciences

Who's Who Legal

2013
Regulatory

PLC Life Sciences Cross-border Handbook

2011-2012
USA – Life Sciences: Regulatory, Recommended

PLC Which Lawyer?

2007-2009
FDA Award of Merit and Special Citation

Secretary's Award for Distinguished Service